A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.
Epistemonikos ID: a6f9211d32496fb9ade05ef0017c89eaae65fb5a
First added on: Oct 01, 2025